Genetics of iron regulation and the possible role of iron in Parkinson's disease

被引:90
|
作者
Rhodes, Shannon L. [1 ]
Ritz, Beate [2 ]
机构
[1] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
关键词
Parkinson's disease; Iron regulatory proteins; Genetics; Pathogenesis;
D O I
10.1016/j.nbd.2008.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is acknowledged as the second most common neurodegenerative disorder after Alzheimer's Disease. Older age may be the only unequivocal risk factor for PD although the male to female ratio is consistently greater than 1 in populations of European ancestry. Characteristic features of PD include dopaminergic neuron death in the substantia nigra (SN) pars compacta, accumulation of alpha-synuclein inclusions known as Lewy bodies in the SN, and brain iron accumulation beyond that observed in non-PD brains of a similar age. In this review article, we will provide an overview of human and animal studies investigating the contributions of iron in PD, a summary of human studies of iron-related genes in PD, a review of the literature on the genetics of iron metabolism, and some hypotheses on possible roles for iron in the pathogenic processes of PD including potential interactions between iron and other factors associated with Parkinson's disease. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:183 / 195
页数:13
相关论文
共 50 条
  • [41] Iron: a causal factor in Parkinson's disease?
    不详
    NEUROSCIENTIST, 2003, 9 (04): : 236 - 236
  • [42] Iron and Parkinson's disease: Chelators to the rescue?
    Levenson, CW
    NUTRITION REVIEWS, 2003, 61 (09) : 311 - 313
  • [43] Glial iron sequestration and Parkinson's disease
    Schipper, HM
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S76 - S76
  • [44] The relevance of iron in the pathogenesis of Parkinson's disease
    Sian-Huelsmann, Jeswinder
    Mandel, Silvia
    Youdim, Moussa B. H.
    Riederer, Peter
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 (06) : 939 - 957
  • [45] Which iron is involved in Parkinson's disease?
    Wszolek, Zbigniew
    Galazka-Friedman, Jolanta
    Wypijewska, Anna
    Jaklewicz, Andrzej
    Elbaum, Danek
    ANNALS OF NEUROLOGY, 2008, 64 : S45 - S45
  • [46] The relevance of iron in the pathogenesis of Parkinson's disease
    Götz, ME
    Double, K
    Gerlach, M
    Youdim, MBH
    Riederer, P
    REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 : 193 - 208
  • [47] α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease
    Sidhu, A
    Wersinger, C
    Vernier, P
    FEBS LETTERS, 2004, 565 (1-3) : 1 - 5
  • [48] Striking While the Iron is Hot: The Role of Prosaposin (PSAP) in Parkinson's Disease
    Lin, Zhi-Hao
    Zhang, Bao-Rong
    MOVEMENT DISORDERS, 2021, 36 (10) : 2224 - 2224
  • [49] The role of glutathione and iron in dopaminergic cell death associated with Parkinson's disease
    Jha, N
    Yantiri, F
    Jurma, O
    Lalli, G
    Liu, Y
    Mo, JQ
    Andersen, JK
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 9 - 9
  • [50] Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Kaur, D
    Andersen, J
    AGEING RESEARCH REVIEWS, 2004, 3 (03) : 327 - 343